EUVIMEDEUVIMED entdecken
Open Access

Mouse Model for Pre‐Clinical Study of Human Cancer Immunotherapy

Zhiya Ya, Yared Hailemichael, Willem Overwijk, Nicholas P Restifo

Current Protocols in Immunology · 2015-02 · 108 (1)

DOI: 10.1002/0471142735.im2001s108 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Protocols in Immunology, online erschienen am 02.02.2015. Verfasst von Zhiya Ya und 3 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Institute, Surgery Branch, Bethesda, Maryland. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This unit describes protocols for developing tumors in mice, including subcutaneous growth, pulmonary metastases of B16 melanoma, and spontaneous melanoma in B‐Raf V600E/PTEN deletion transgenic mouse models. Two immunization methods to prevent B16 tumor growth are described using B16.GM‐CSF and recombinant vaccinia virus. A therapeutic approach is also included that uses adoptive transfer of tumor antigen–specific T cells. Methods including CTL induction, isolation, testing, and genetic modification of mouse T cells for adoptive transfer by using retrovirus‐expressing genes of interest are provided. Additional sections, including growing B16 melanoma, enumerating pulmonary metastases, tumor imaging technique, and use of recombinant viruses for vaccination, are discussed together with safety concerns. © 2015 by John Wiley & Sons, Inc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyAnimalsAntibodiesCancer VaccinesCell Culture TechniquesCell- and Tissue-Based TherapyDisease Models, AnimalEnzyme-Linked Immunosorbent AssayFemaleGene Transfer TechniquesGenetic VectorsImmunizationMaleMelanoma, ExperimentalMiceMice, TransgenicMolecular ImagingNeoplasm MetastasisNeoplasmsReceptors, Antigen, T-CellT-Lymphocyte Subsets

Stichwörter der Autor:innen

B16 melanomatranslational cancer immunotherapytumor imaginguse of recombinant viruses for vaccination

Substanzen

AntibodiesCancer VaccinesReceptors, Antigen, T-Cell

Autor:innen und Institutionen

  • National Cancer Institute, Surgery Branch, Bethesda, Maryland.
  • Department of Melanoma Medical Oncology-Research, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Förderung

  • Intramural NIH HHS

Zitieren

APA

Ya, Z., Hailemichael, Y., Overwijk, W., & Restifo, N. P. (2015). Mouse Model for Pre‐Clinical Study of Human Cancer Immunotherapy. Current Protocols in Immunology, 108(1). https://doi.org/10.1002/0471142735.im2001s108

Vancouver

Ya Z, Hailemichael Y, Overwijk W, Restifo NP. Mouse Model for Pre‐Clinical Study of Human Cancer Immunotherapy. Current Protocols in Immunology. 2015;108(1). doi:10.1002/0471142735.im2001s108

BibTeX
@article{Ya2015,
  author = {Ya, Zhiya and Hailemichael, Yared and Overwijk, Willem and Restifo, Nicholas P},
  title = {Mouse Model for Pre‐Clinical Study of Human Cancer Immunotherapy},
  journal = {Current Protocols in Immunology},
  year = {2015},
  volume = {108},
  number = {1},
  doi = {10.1002/0471142735.im2001s108}
}
Kostenlos starten →